Cellular Oncology

Papers
(The H4-Index of Cellular Oncology is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Angiogenesis as a hallmark of solid tumors - clinical perspectives107
Oxaliplatin induces immunogenic cell death in hepatocellular carcinoma cells and synergizes with immune checkpoint blockade therapy75
The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities70
Downregulated exosomal microRNA-148b-3p in cancer associated fibroblasts enhance chemosensitivity of bladder cancer cells by downregulating the Wnt/β-catenin pathway and upregulating PTEN65
Current insights into the metastasis of epithelial ovarian cancer - hopes and hurdles63
DNMT1 as a therapeutic target in pancreatic cancer: mechanisms and clinical implications54
Role of CK2 inhibitor CX-4945 in anti-cancer combination therapy – potential clinical relevance49
The role of tumor-associated macrophages in osteosarcoma progression – therapeutic implications44
Pharmacogenomics of 5-fluorouracil in colorectal cancer: review and update44
Porphyromonas gingivalis promotes tumor progression in esophageal squamous cell carcinoma43
Macrophage-secreted MMP9 induces mesenchymal transition in pancreatic cancer cells via PAR1 activation40
CircRNA BIRC6 promotes non-small cell lung cancer cell progression by sponging microRNA-14538
A comprehensive review of SHP2 and its role in cancer33
MT1JP-mediated miR-24-3p/BCL2L2 axis promotes Lenvatinib resistance in hepatocellular carcinoma cells by inhibiting apoptosis33
CAR T cell therapy as a promising approach in cancer immunotherapy: challenges and opportunities30
Immunosuppression, immune escape, and immunotherapy in pancreatic cancer: focused on the tumor microenvironment28
Prognostic role of proliferating CD8+ cytotoxic Tcells in human cancers28
HDAC6: A unique HDAC family member as a cancer target26
[10]-Gingerol improves doxorubicin anticancer activity and decreases its side effects in triple negative breast cancer models26
Upregulation of TTYH3 promotes epithelial-to-mesenchymal transition through Wnt/β-catenin signaling and inhibits apoptosis in cholangiocarcinoma26
Non-coding RNAs underlying chemoresistance in gastric cancer26
HIF1A expression correlates with increased tumor immune and stromal signatures and aggressive phenotypes in human cancers25
Protein arginine methyltransferase 5: a potential cancer therapeutic target25
Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer25
LncRNA PVT1 induces aggressive vasculogenic mimicry formation through activating the STAT3/Slug axis and epithelial-to-mesenchymal transition in gastric cancer24
Terminal α2,6-sialylation of epidermal growth factor receptor modulates antibody therapy response of colorectal cancer cells24
Functional and metabolic targeting of natural killer cells to solid tumors24
0.024768829345703